Volver

McKesson Corporation

Ticker: MCK ISIN: US58155Q1031
Añadir al portafolio Análisis de cartera en 2min
Stock Large-cap Dividend payer Trading above 200-day average
Capitalización
100,76 MM $
P/E
23,75
Forward P/E
18,87
Profit margin
1,09%
Revenue growth QoQ
11,40%
Div. yield
0,37%
Beta
0,42
858,90 $ 2,40%
Precio a fecha de 2026-08-21 · NYSE

Rendimiento por período

Rendimientos acumulados
1 Month +2,14%
6 Months -9,34%
1 Year +27,03%
5 Years +34,54% p.a.+340,33%
10 Years +17,61% p.a.+405,83%
Since inception +13,98% p.a.+2 529,17%
Rendimientos por año
YTD +4,91%
2025 +44,54%
2024 +23,67%
2023 +24,13%
2022 +51,83%
2021 +44,23%

Key stats

Market cap
100,76 MM
P/E
23,75
Dividend yield
0,37%
Beta
0,42
52-week range
635.12 - 999.00
50-day MA
898,67
200-day MA
811,75
Section 1

Business overview

Company profile data from fundamentals.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Sector Healthcare
Industry Medical Distribution
Country United States
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 0,00%
ROA 4,33%
Profit margin 1,09%
Operating margin 1,55%
PEG ratio 1,02
Revenue/share TTM 3.202,88
Revenue TTM 397,96 MM
EBITDA 5,93 MM
Gross profit TTM 13,74 MM
Beta 0,42

Valuation

Trailing P/E 23,75
Forward P/E 18,87
P/B 5,04
P/S 0,25
EV/EBITDA 16,59
EV/Revenue 0,27

ESG Scores

Total ESG 23,8
Environment 9,1
Social 17,1
Governance 12,5
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 39,01
Quarterly earnings growth 38,00%
Revenue TTM 397,96 MM
Reported quarters 118
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 0,37%
Forward annual div. yield 0,43%
Dividend per share 3,0600
Payout ratio 9,43%
Ex-dividend date 2025-03-03
Next dividend date 2026-07-01
Split factor 2:1
Last split date 1998-01-05
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 650,48 $
Analyst rating 4.3529

Ownership & short interest

Shares outstanding 125,33 M
Shares float 125,09 M
Institutional ownership 89,82%
Insider ownership 7,50%
Short ratio 3,34
Short % of float 2,11%

Details

Instrument metadata and source update timestamps.

Symbol MCK
Name McKesson Corporation
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US58155Q1031
Country USA
Code + exchange MCK.NYSE
Last price date 2026-04-29
Fundamentals updated 2026-04-30

La información proporcionada en esta plataforma es solo para fines informativos y no debe considerarse como asesoramiento financiero o de inversión. Insightfolio no ofrece asesoramiento financiero, recomendaciones personalizadas ni orientación sobre la compra, tenencia o venta de activos financieros. Las herramientas y contenidos son únicamente educativos y no están adaptados a las circunstancias, necesidades financieras u objetivos personales.

Insightfolio no asume ninguna responsabilidad por la precisión, integridad o fiabilidad de la información presentada. Es responsabilidad exclusiva de los usuarios verificar la información y tomar decisiones independientes basándose en su propia investigación y consideración. El uso de esta plataforma no reemplaza la consulta con profesionales financieros cualificados.

Invertir implica riesgos. Los usuarios deben ser conscientes de que el valor de las inversiones puede fluctuar y que los rendimientos pasados no son garantía de resultados futuros. Las decisiones de inversión deben basarse en objetivos financieros personales, tolerancia al riesgo y una evaluación independiente de la información relevante.

Insightfolio no respalda ni garantiza la idoneidad de ningún producto financiero, valor o estrategia en particular. Cualquier proyección, pronóstico o escenario hipotético presentado en la plataforma es solo ilustrativo y no constituye una garantía.

Al acceder a los servicios, información o contenido ofrecido por Insightfolio, los usuarios reconocen y aceptan los términos de este aviso legal. Si no estás de acuerdo con estos términos, por favor no uses nuestra plataforma.

Logotipos de instrumentos proporcionados por Elbstream.